2nd Quarter - Report

MEHLMAN CONSULTING, INC. for MAYO CLINIC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Fiscal Year 2018 Labor and Health and Human Services Appropriations.

Contacted: SENATE; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Office of Science & Technology Policy (OSTP); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Quality payments for providers; clinical laboratory reimbursement; physician payment policies; chronic healthcare.

Contacted: Executive Office of the President (EOP); SENATE; Health & Human Services, Dept of (HHS); Office of Science & Technology Policy (OSTP); HOUSE OF REPRESENTATIVES

Health Issues HCR

General healthcare; health reform implementation; healthcare value and quality; health information technology, clinical trials, telehealth. Precision Medicine Act of 2016. Promoting biomedical research. H.R. 6 - Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act. S. 3120 - Helping to End Addiction and Lessen (HEAL) Substance Use Disorders Act of 2018. S. 2680 - Opioid Crisis Response Act of 2018.

Contacted: Office of Science & Technology Policy (OSTP); SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS)

Bills named: S. 3120 (115th), H.R. 6 (115th), S. 2680 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.